vaccines

24 Aug 2020

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University and the UK CPI, Wilton, since the start of the outbreak, and the collaboration is...

04 Aug 2020

Zoetis introduces range of first world innovations to SA agriculture

Agriculture will play a critical role in the economic recovery of South Africa in the wake of the COVID-19 pandemic. In light of this, animal health company, Zoetis, intends introducing a plethora of first world innovations that will help local farmers to increase productivity and, ultimately, contribute towards food security in the region. “We want...

07 Jul 2020

Flatten the curve with Esco, your partner in Biosafety bioprocessing

Esco VacciXcell provides an ideal bioprocessing platform and tools for high cell/product yield at a low cost for various applications such as vaccines and cell therapy.